Why the study?
Does angiotensin converting enzyme inhibitors prevent progression of deterioration in renal function in patients with diabetic nephropathy?
Population
Patients with diabetic nephropathy (in the presence or absence of hypertension)
Design
Review
Authors
Loading...
Supports early ACE inhibitor use at microalbuminuria in diabetes; leaves open need for updated RCTs with contemporary therapies.
Does angiotensin converting enzyme inhibitors prevent progression of deterioration in renal function in patients with diabetic nephropathy?
ACE inhibitors provide specific renal protection in diabetic nephropathy, slowing or potentially arresting disease progression when initiated early.
Maxwell et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: